key: cord-0860489-8s320x3c
authors: Ramsey, Allison; Yang, Luanna; Vadamalai, Karthik; Mustafa, S. Shahzad
title: Appointment Characteristics in an Allergy/Immunology Practice in the Immediate Aftermath of COVID-19 Restrictions
date: 2020-05-26
journal: J Allergy Clin Immunol Pract
DOI: 10.1016/j.jaip.2020.05.017
sha: 5cacc5e3c76327f46431077daefb6f9571d3f1e2
doc_id: 860489
cord_uid: 8s320x3c

nan

We retrospectively collected encounter data for the three week period from March 16 -April 3, 57 2020 for three physicians at Rochester Regional Health (RRH) Allergy and Immunology. The most common incomplete diagnosis was food allergy in 13 (32.5%) patients. FU encounters 98 were deemed to be complete more often than NP encounters (p=0.0002). There was no 99 difference in completeness of visits completed via telephone versus telemedicine (p=0.400). 100 Guidelines suggesting allergy/immunology office response to the COVID-19 pandemic are in 101 press (5). Telemedicine has emerged as a strategy to continue allergy/immunology patient 102 evaluations (6) in the COVID-19 era. Our analysis provides early information on the 103 implementation of some of these recommendations. 104 There is good news to be gleaned from our data. Although almost half of scheduled patients 105 cancelled, 55% of patients received medical care. In patients with immediate need, such as an 106 asthma exacerbation, acute urticaria, or acute sinusitis, remote care aids in social distancing 107 efforts and unburdens emergency departments. Remote care also reinforces to patients the 108 message of the necessity of social distancing. Additionally, over 75% of our FU encounters were 109 considered complete. This is helpful information given the uncertainty COVID-19 restriction 110 duration. Furthermore, although allergists have been slow to adopt telemedicine (7), 111 telemedicine for FU encounters may be a feasible option after resolution of the COVID-19 112 pandemic. Certain diagnoses lend themselves particularly well to these types of encounters. 113 Telemedicine can also offer care to areas without allergy access. 114 Unfortunately, despite some good news, our data highlights the unsustainability of the current 115 approach. Nearly half of patients had evaluations cancelled, including all food and drug 116 challenges. Additionally, almost half of the NP evaluations were deemed incomplete. Although 117 skin testing is not always completed for NP evaluations, the majority of these incomplete visits 118 were due to the inability to perform skin testing, a diagnostic modality of considerable 119 importance to our specialty, and cannot be done with a telemedicine evaluation of a patient at 120 home. Despite our office encouraging telemedicine encounters to patients, telephone 121 encounters were the most common. We suspect patients did not have the comfort level and/or 122 access to the needed technology. Amongst other shortcomings, telephone encounters do not 123 provide viable reimbursement to maintain a medical practice. 124 Our analysis helps define what allergists across the country faced during the immediate 125 aftermath of the COVID-19 pandemic, and this is the main strength of our report. We 126 acknowledge that the retrospective nature of our study is a limitation. Although the 127 generalizability and implications of our findings will be different among academic, employed, 128 and private practice settings, we hope this data highlights the marked patient care and financial 129 ramifications of the immediate response to the COVID-19 pandemic. These metrics can be used 130 to guide our evolving response in the coming weeks and months, and also potentially aid in 131 important advocacy efforts for our specialty. It will remain imperative to monitor the ongoing 132 response to the COVID-19 pandemic, and we hope ours and future data will identify successes, 133 challenges, and areas of needed focus and advocacy. 

Clinical Characteristics of Coronavirus Disease 151 2019 in China

Case Investigation Team, First case of 2019 novel Coronavirus in the United States

Centers for Disease Control and Prevention. Coronaviurs disease 2019COVID-19) situation summary

New York State Information on Novel Coronavirus

Contingency Planning for the Allergy and Immunology Clinic

Epub ahead of print

Telemedicine in the Era of COVID-19

Telemedicine and Digitall Health Survey